Showing results (21-30 of 125) with videos related to
Sort By:
Pageof 13
Texas Heart Institute Journal|November 27, 2014
Cardiac plasmacytoma: a rare clinical entityAgathi-Rosa Vrettou, L Thompson Heffner, Peter J Rossi, et al.Journal of Surgical Oncology|September 18, 2009
Lymphadenectomy for patients with cervical cancer: is it of value?Peter J Rossi, Ira R Horowitz, Peter A S Johnstone, et al.International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomesScott Edelman, Stanley L Liauw, Peter J Rossi, et al.International Journal of Radiation Oncology, Biology, Physics|September 15, 2007
Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysisPeter J Rossi, Ashesh B Jani, Ira R Horowitz, et al.Frontiers in Oncology|February 18, 2021
Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case ReportMehmet A Bilen, James F Jiang, Caroline S Jansen, et al.Vascular and Endovascular Surgery|September 17, 2011
Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infectionElisabeth Frei, Kelley Hodgkiss-Harlow, Peter J Rossi, et al.Journal of Vascular Surgery Cases and Innovative Techniques|August 21, 2025
Extracorporeal membrane oxygenation use in open thoracoabdominal aortic aneurysm repairCarl T Schoephoerster, James E Mace, Mitchell R Dyer, et al.Journal of Vascular Surgery Cases and Innovative Techniques|November 29, 2023
Management of spontaneous dissection and rupture of common iliac artery in vascular Ehlers-Danlos syndrome (VEDS)Simon Fraser, Peter J Rossi, Eric J Hohenwalter, et al.Journal of Vascular Surgery|January 29, 2013
Ruptured mycotic infrapopliteal aneurysmIrina Shakhnovich, Gary R Seabrook, Kellie R Brown, et al.Brachytherapy|October 22, 2008
Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alonePeter J Rossi, James Urbanic, Peter E Clark, et al.Pageof 13